Pursuant to Regulation 30 of SEBI Listing Regulations, please find attached Press Release titled, "Zaynich TM (Zidebactam/Cefepime, WCK 5222) enables US cancer patient undergo successful liver transplant and resume chemotheraphy by eradicating dual extreme-drug resistant Gram negative pathogens"